Our results showing a favorable prognosis in younger patients with a high number of intratumoral CD68+CLEVER-1+ TAMs may be linked with hereditary Lynch syndrome, which is characterized by mutations in the MMR genes leading to MSI-H tumors. The gene discussed is MRC1; the disease is Lynch syndrome.